HTLV-I-associated myelopathy following allogeneic bone marrow transplantation.
A 39-year-old polytransfused patient with aplastic anemia acquired transfusion-associated HTLV-I infection shortly before transplantation. The patient underwent allogeneic bone marrow transplantation and developed HTLV-I associated myelopathy 3 years later. Clinical abnormalities and a host of atypical findings are presented in the context of previous reports describing uncommon features of the disease.
Emmanouilides
C E
CE
Department of Medicine, UCLA Center for the Health Sciences, Los Angeles, CA, USA.
Territo
M
M
D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications* / Q000628:therapy; D005260:Female; D015490:HTLV-I Infections / Q000635:transmission*; D015368:Human T-lymphotropic virus 1 / Q000302:isolation & purification*; D006801:Humans; D015493:Paraparesis, Tropical Spastic / Q000209:etiology* / Q000821:virology; D065227:Transfusion Reaction